Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tugwell

Showing results (251-260 of 301) with videos related to

Pageof 31
Sort By:
The New England Journal of Medicine|July 20, 1995
Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study GroupP Tugwell, T Pincus, D Yocum, et al.
The Journal of Rheumatology|April 1, 1997
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT IIIN Bellamy, J Kirwan, M Boers, et al.
Osteoarthritis and Cartilage|July 20, 2002
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical resultsJ-P Raynauld, G W Torrance, P A Band, et al.
Osteoarthritis and Cartilage|July 20, 2002
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic resultsG W Torrance, J P Raynauld, V Walker, et al.
Arthritis and Rheumatism|September 1, 1996
Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A. An update from the International Kidney Biopsy RegistryF Rodríguez, J C Krayenbühl, W B Harrison, et al.
Pharmacoeconomics|May 7, 1996
Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for PharmacoeconomicsG W Torrance, D Blaker, A Detsky, et al.
BMC Public Health|June 14, 2006
Health Research Profile to assess the capacity of low and middle income countries for equity-oriented researchP Tugwell, C Sitthi-Amorn, J Hatcher-Roberts, et al.
Annals of Internal Medicine|December 31, 1997
Laboratory evaluation in the diagnosis of Lyme diseaseP Tugwell, D T Dennis, A Weinstein, et al.
Osteoarthritis and Cartilage|August 9, 2015
Impact of patient decision aids on appropriate and timely access to hip or knee arthroplasty for osteoarthritis: a randomized controlled trialD Stacey, M Taljaard, G Dervin, et al.
Rheumatology (Oxford, England)|February 22, 2003
A simplified disease activity index for rheumatoid arthritis for use in clinical practiceJ S Smolen, F C Breedveld, M H Schiff, et al.
Pageof 31

Showing results (251-260 of 301) with videos related to

Sort By:
Pageof 31
The New England Journal of Medicine|July 20, 1995
Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study GroupP Tugwell, T Pincus, D Yocum, et al.
The Journal of Rheumatology|April 1, 1997
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT IIIN Bellamy, J Kirwan, M Boers, et al.
Osteoarthritis and Cartilage|July 20, 2002
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical resultsJ-P Raynauld, G W Torrance, P A Band, et al.
Osteoarthritis and Cartilage|July 20, 2002
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic resultsG W Torrance, J P Raynauld, V Walker, et al.
Arthritis and Rheumatism|September 1, 1996
Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A. An update from the International Kidney Biopsy RegistryF Rodríguez, J C Krayenbühl, W B Harrison, et al.
Pharmacoeconomics|May 7, 1996
Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for PharmacoeconomicsG W Torrance, D Blaker, A Detsky, et al.
BMC Public Health|June 14, 2006
Health Research Profile to assess the capacity of low and middle income countries for equity-oriented researchP Tugwell, C Sitthi-Amorn, J Hatcher-Roberts, et al.
Annals of Internal Medicine|December 31, 1997
Laboratory evaluation in the diagnosis of Lyme diseaseP Tugwell, D T Dennis, A Weinstein, et al.
Osteoarthritis and Cartilage|August 9, 2015
Impact of patient decision aids on appropriate and timely access to hip or knee arthroplasty for osteoarthritis: a randomized controlled trialD Stacey, M Taljaard, G Dervin, et al.
Rheumatology (Oxford, England)|February 22, 2003
A simplified disease activity index for rheumatoid arthritis for use in clinical practiceJ S Smolen, F C Breedveld, M H Schiff, et al.
Pageof 31